Diagnostic Imaging's A Look Ahead: July 19 to July 23, 2021
Here's what to expect this week on Diagnostic Imaging.
In this week’s preview, here are some highlights of what you can expect to see coming soon:
Racial disparities are a known problem in healthcare, including radiology. These inequities can also lead to diagnostic delays. An article published later this week will take a look at how these racial disparities and diagnostic delays affect women with breast cancer.
For more breast imaging coverage, click here.
Emergency situations – pandemic or otherwise – can cause great confusion. Having a well-designed strategy in place can ensure the fastest and most accurate dissemination of information and care. Look for an article later this week about the impact of a radiology call center hotline.
For more coverage of radiology consultations, click here.
For more coverage based on industry expert insights and research, subscribe to the Diagnostic Imaging e-Newsletter here.
Dental pathology can be overlooked in radiologic scans. But, a new investigation published in the Journal of Digital Imaging, shows that adding a one-slice series on a CT scan of the neck can reduce time-to-diagnosis for patients. Look for the article alter this week.
For more coverage of dental pathology, click here.
SNMMI: Can 18F-Fluciclovine PET/CT Bolster Detection of PCa Recurrence in the Prostate Bed?
June 24th 2025In an ongoing prospective study of patients with biochemical recurrence of PCa and an initial negative PSMA PET/CT, preliminary findings revealed positive 18F-fluciclovine PET/CT scans in over 54 percent of the cohort, according to a recent poster presentation at the SNMMI conference.
Could an Emerging PET Tracer be a Game Changer for Detecting Hepatocellular Carcinoma?
June 23rd 2025In addition to over 90 percent sensitivity in detecting hepatocellular carcinoma (HCC), the glypican-3 (GPC3) targeted PET tracer 68Ga-aGPC3-scFv appeared to be advantageous in identifying HCC tumors smaller than one centimeter, according to pilot study findings presented at the SNMMI conference.
SNMMI: What a New Meta-Analysis Reveals About Radiotracers for PET/CT Detection of PCa
June 22nd 2025While (68Ga)Ga-PSMA-11 offers a pooled sensitivity rate of 92 percent for prostate cancer, (18F)-based radiotracers may offer enhanced lesion detection as well as improved imaging flexibility, according to a meta-analysis presented at the Society for Nuclear Medicine and Molecular Imaging (SNMMI) conference.
